![Amneal Pharmaceuticals Inc](/common/images/company/N_AMRX.png)
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 548.3M | 609.73M | 559.2M | 602.5M | 617.89M | 629.65M | 659.19M | 701.78M |
Operating Income | 44.35M | 36.03M | 34.45M | 80.08M | 75.65M | 14.19M | -10.65M | 95.47M |
Pre Tax Income | 2.18M | -7.66M | -9.43M | 29.66M | 22.96M | -83.46M | -75.52M | 20.41M |
Net Income | -2.69M | -4.33M | -6.94M | 11.92M | 9.68M | -98.65M | -91.64M | 5.99M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 51.68M | 38.8M | 37.99M | 80.1M | 76.81M | 14.6M | -8.52M | 86.39M |
EBITDA | 111.75M | 104.27M | 92.6M | 137.2M | 132.85M | 101.93M | 44.88M | 151.04M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 1.69B | 1.63B | 1.99B | 2.09B | 2.22B | 2.41B |
Operating Income | 0 | -19.67M | -248.68M | 91.16M | 158.08M | -96.84M | 204.37M |
Pre Tax Income | 0 | -202.72M | -220.24M | -35.78M | 31.37M | -248.13M | -40.27M |
Net Income | 0 | -20.92M | -361.92M | 91.06M | 10.62M | -129.99M | -83.99M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | -0.049 | -0.811 | 0.101 | 0.012 | -0.143 | -0.069 |
EBIT | 0 | -39.45M | -47.08M | 93.87M | 168.05M | -77.1M | 209.49M |
EBITDA | 0 | 165.66M | 5.17M | 329.22M | 391.49M | 156.31M | 464.57M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.